Sarasota, Inc., a drug company, reported the following information. The company prepares its financial statements in accordance with GAAP 2020 (,000) Current liabilities $552,275 Convertible subordinated debt 648,658 Total liabilities 1,228,281 Stockholders' equity Net income 177,805 57,397 Analysts attempting to compare Sarasota to drug companies that issue debt with detachable warrants may face a challenge due to differences in accounting for convertible debt.